Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus

被引:74
|
作者
Wong, R. H. X. [1 ]
Nealon, R. S. [1 ]
Scholey, A. [2 ]
Howe, P. R. C. [1 ]
机构
[1] Univ Newcastle, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Univ Dr,Med Sci Bldg,MS304, Callaghan, NSW 2308, Australia
[2] Swinburne Univ, Ctr Human Psychopharmacol, Hawthorn, Vic 3122, Australia
基金
英国医学研究理事会;
关键词
Cerebrovascular circulation; Diabetes mellitus; Nutrition; Vasodilatation; INSULIN-RESISTANCE; NITRIC-OXIDE; REACTIVITY; RESPONSIVENESS; FLOW;
D O I
10.1016/j.numecd.2016.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Progressive microvascular dysfunction in type 2 diabetes mellitus (T2DM) may impair the ability of cerebral vessels to supply blood to brain regions during local metabolic demand, thereby increasing risks of dementia. Having previously demonstrated that resveratrol can enhance vasodilator function in the systemic circulation, we hypothesised that resveratrol could similarly benefit the cerebral circulation. We aimed to determine the most efficacious dose of resveratrol to improve cerebral vasodilator responsiveness (CVR) in T2DM. Methods and results: In a double-blind, placebo-controlled, balanced crossover intervention, 36 dementia-free, non-insulin dependent T2DM older adults (49-78 years old) consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. Transcranial Doppler ultrasound was used to assess CVR to a hypercapnic stimulus, both before and 45 min after treatment. CVR, measured bilaterally in the middle cerebral arteries (MCA) and posterior cerebral arteries (PCA), was expressed as the percentage change in mean blood flow velocity from baseline to the peak velocity attained during hypercapnia. Resveratrol consumption increased CVR in the MCA; mean within-individual changes for each dose from placebo were 13.8 +/- 3.5% for 75 mg (P = 0.001), 8.9 +/- 3.5% for 150 mg (P = 0.016), and 13.7 +/- 3.3% for 300 mg (P < 0.001); only the 75 mg dose was efficacious in the PCA (13.2 +/- 4.5%, P = 0.016). Conclusions: Our results provide the first clinical evidence of an acute enhancement of vasodilator responsiveness in cerebral vessels following consumption of resveratrol in this population who are known to have endothelial dysfunction and sub-clinical cognitive impairment. Importantly, maximum improvement was observed with the lowest dose used. (C) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 50 条
  • [31] GASTRIC BYPASS IMPROVES HEPATIC MITOCHONDRIAL FUNCTION IN PATIENTS WITH SIMULTANEOUS STEATOHEPATITIS AND TYPE 2 DIABETES MELLITUS Type 2 diabetes and metabolic surgery
    Billeter, A.
    Scheurlen, K.
    Israel, B.
    Buechler, M.
    Nawroth, P.
    Mueller-Stich, B.
    OBESITY SURGERY, 2017, 27 : 259 - 259
  • [32] Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
    Mori, Hiroko
    Okada, Yosuke
    Arao, Tadashi
    Tanaka, Yoshiya
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) : 313 - 319
  • [33] Effect of Resveratrol on the intestinal microbiota in Type2 diabetes Mellitus mice
    Liu, Hao
    Wang, Shumin
    Yu, Xin
    Sun, Shuguang
    Su, Yingzhen
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2025, 56 (01) : 447 - 463
  • [34] Influence of hypertension and type 2 diabetes mellitus on cerebrovascular reactivity in diabetics with retinopathy
    Ivankovic, Mira
    Radman, Maja
    Gverovic-Antunica, Antonela
    Tesanovic, Sanda
    Trgo, Gorana
    Demarin, Vida
    ANNALS OF SAUDI MEDICINE, 2013, 33 (02) : 130 - 133
  • [35] LOW-DOSE PIOGLITAZONE UTILISATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN THE UNITED KINGDOM
    Zhao, C.
    Zhang, Q.
    Davies, M. J.
    Steinberg, H.
    VALUE IN HEALTH, 2011, 14 (07) : A484 - A484
  • [36] Anxiety and depressive disorders in patients with diabetes mellitus type 2 and cerebrovascular disease
    Dubinina, I. I.
    Zhadnov, V. A.
    Yankina, S., V
    Solovjeva, A., V
    DIABETES MELLITUS, 2012, 15 (04): : 59 - 62
  • [37] Low-dose rosiglitazone in patients with type 2 diabetes mellitus requiring insulin therapy
    Lopez, Cesar A.
    Kanna, Balavenkatesh
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (05) : 548 - 548
  • [38] Effect of Type 2 Diabetes Mellitus on Pulmonary Function
    Huang, H.
    Guo, Q.
    Li, L.
    Lin, S.
    Lin, Y.
    Gong, X.
    Yao, J.
    Liang, J.
    Lin, L.
    Wen, J.
    Chen, G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (06) : 322 - 326
  • [39] Liver function in the patients with diabetes mellitus type 2
    Alibasic, Esad
    Ljuca, Farid
    Nuhbegovic, Sabina
    Zildzic, Muharem
    Poljakovic, Dzemal
    HEALTHMED, 2008, 2 (02): : 89 - 94
  • [40] Type 2 Diabetes Mellitus and Cognitive Function in the Elderly
    Malekian, Nazila
    Hosseini, Seyed Reza
    Moudi, Sussan
    Bayani, Mohammad Ali
    Kheirkhah, Farzan
    Bijani, Ali
    Khalilipour, Aylar
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2018, 12 (02)